Praxis Precision Medicines, Inc. PRAX License — Contract with customer, liability, revenue recognized
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityRevenueRecognized.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s license — contract with customer, liability, revenue recognized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s license — contract with customer, liability, revenue recognized?
- Praxis Precision Medicines, Inc. (PRAX) reported license — contract with customer, liability, revenue recognized of $0 in Q1 2026.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s license — contract with customer, liability, revenue recognized?
- Over 2 years (2023 to 2025), Praxis Precision Medicines, Inc.'s license — contract with customer, liability, revenue recognized has grown at a -100.0% compound annual growth rate (CAGR), from $2.4M to $0.
- What does license — contract with customer, liability, revenue recognized mean?
- The portion of deferred revenue from licensing contracts that has been recognized as income during the reporting period as performance obligations are satisfied. This reflects the conversion of contract liabilities into earned revenue as the company fulfills its research or development commitments.